(Adds source in the headline)
(Reuters) – About 15 million doses of Johnson & Johnson’s COVID-19 vaccine have been ruined due to a mixup at a Baltimore plant, forcing regulators to delay authorization of the plant’s production lines, New York Times reported on Wednesday.
The plant is run by Emergent BioSolutions, a manufacturing partner to both Johnson & Johnson and AstraZeneca Plc, according to the report. (This story refiles to add source in the headline)
(Reporting by Dania Nadeem in Bengaluru; Editing by Anil D’Silva)
